Do Multivitamins Actually Improve Your Health? What Clinical Trials Reveal
Millions of adults take daily multivitamin supplements in the hope of safeguarding their wellness and preventing chronic illness. However, a scoping review published in the Journal of Dietary Supplements examines decades of clinical trial evidence to determine whether these widely used products actually deliver clinical health benefits beyond raising circulating nutrient markers.
What the Clinical Evidence Shows
Led by researchers including senior author Taylor C. Wallace, the review analyzed peer-reviewed studies published through September 2026. The authors sought to evaluate the safety and efficacy of broad-spectrum multivitamin formulations across various adult populations. The results indicate that while supplements consistently elevate circulating levels of certain nutrients—most notably folate, vitamin B6, and vitamin B12—these biochemical improvements do not automatically translate into broader health outcomes.
The review noted that mineral levels showed less consistent responses, with outcomes for iron, zinc, and iodine varying widely based on individual circumstances and baseline nutrition. Furthermore, while selected trials suggested positive findings for cognitive test performance or pregnancy-related measures, the effects depended heavily on the specific population studied, the formulation used, and the duration of supplementation.
Key Findings Across Different Health Endpoints
The analyzed trials revealed mixed results across various medical and physiological categories:
- Pregnancy and Infants: Some studies, such as the JiVitA-3 trial, reported that multiple micronutrients reduced low birth weight and preterm births compared to iron and folic acid alone, though infant mortality reductions varied.
- Cognition: Analyses from the COSMOS trial initiative reported benefits for specific memory and global cognition measures. However, other large efforts like the Physicians’ Health Study II found no overall cognitive benefit, leaving dementia prevention unproven.
- Chronic Disease: Major trials like PHS-II and COSMOS did not establish overall cardiovascular preventive effects, though PHS-II noted modest reductions in cataracts and total cancer incidence in specific cohorts.
Safety Considerations and Limitations
Multivitamins were generally well tolerated by pregnant women, older adults, and post-surgical patients. However, formulations containing iron or zinc occasionally caused mild digestive complaints. More notably, large trials reported specific adverse events, such as increased gastrointestinal bleeding in the COSMOS study and modest increases in rashes and nosebleeds in PHS-II. The authors also highlighted that vitamin K can interfere with anticoagulant medications like warfarin, emphasizing the importance of medical guidance.
The researchers acknowledged several limitations in the underlying literature. The review did not perform a meta-analysis or formally assess the risk of bias, restricting definitive conclusions regarding the magnitude of reported benefits. The authors noted that future research requires standardized formulations, validated outcomes, and clearly defined clinical goals to better understand how multivitamins affect diverse populations.
